Home » About SARC » Team
We are researchers and investigators at sarcoma centers working together with pharmaceutical and biotech companies to achieve breakthroughs in sarcoma – to help improve patient outcomes, and ultimately find a cure.
The SARC organization is set up as a directorship, and the organization’s overall strategy and policy is guided by members of the board. Our scientific platform is established by leaders who are recognized experts in sarcoma research. Within this organizational structure we are positioned to bring together the range of expertise needed to move the science of sarcoma forward to develop new and better treatments for patients with sarcoma.
Board of Directors
Scientific Steering Committee
Clinical Trialist Development Committee and Local Control Working Group
Multidisciplinary Tumor Board
Research Advocacy Council
The team of individuals at SARC’s operations office provides the range of expertise needed to support the organization’s scientific leadership and sustain the infrastructure necessary to facilitate the conduct of research.
Research Project Manager
Director of Business Operations
Senior Research Project Manager
Director of Finance
President & CEO, SARC
Under the guidance of the Board of Directors, SARC’s policies and strategies are established and refined on a regular basis. Our board consists of individuals from a range of backgrounds and areas of expertise to ensure that different viewpoints are represented as strategies are crafted to support SARC’s mission. The board meets quarterly, and as needed, to conduct the important business of SARC.
Chair of the Board, SARC
Corporate Secretary, SARC
Corporate Treasurer, SARC
The Scientific Steering Committee (SSC) serves as the executive, multidisciplinary, scientific and clinical team guiding SARC’s research priorities and course. The SSC advises on the gamut of SARC programs. Further, the SSC evaluates external proposals for new clinical trials and post-hoc proposals for use of biomaterials, imaging studies, and/or clinical data from previous trials. In addition, the SSC collaborates with the SARC Discovery/Translation Committee in creating agendas for SARC conferences
Chief Scientific Officer, SARC
Scientific Steering Committee and Local Control Working Group
Chief Medical Officer, SARC
The Discovery/Translation Committee’s mandate is to expand SARC’s commitment to mechanistic and translational sarcoma science. One of the Committee’s goals is to integrate cutting edge biomarkers and discovery science in SARC clinical trials, seeking to understand why new therapies help some people and not others. Another commitment is organizing sarcoma science working groups and conferences for sarcoma investigators in basic or translational research fields. These efforts complement and intersect with SARC’s core commitment to clinical investigation in sarcoma.
The purpose of SARC’s Clinical Trialist Development Committee & Local Control Working Group is to generate Sarcoma clinical trial proposals, to support young investigators in developing and submitting trials concepts, and to engage clinical trialists and industry to pursue clinical trials in sarcoma.
Local Control Working Group
The SARC Multidisciplinary Tumor Board (SMTB) is a team of experts from a wide range of specialties that meet monthly for in-depth, evidence-based discussion of tumor diagnosis and management. More about SMTB
The SARC Research Advocacy Council (RAC) was created using the model established by the National Cancer Institute (NCI) for engagement of patient advocates to become “research advocates” across four key functions: advise, design, review, and disseminate. A number of individual patient advocates have agreed to serve as research advocates on the SARC Research Advocacy Council. The council convenes regularly to explore opportunities to interface with researchers. More about RAC
Sign up for our monthly SARC newsletter and updates on clinical trials.